Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 juil. 2024 13h30 HE | Source: Custom Market Insights

[Latest] US Biotechnology Market Size/Share Worth USD 1797.8 Billion by 2033 at a 12.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, July 25, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Biotechnology Market Size, Trends and Insights By Technology...
28 juin 2023 11h05 HE | Source: PMI

[New Report] Induced Pluripotent Stem Cells Market is estimated to be US$ 3.5 billion by 2032; Growing Prevalence of Diseases and Demand for Therapies to Foster Industrial Growth - By PMI

Covina, June 28, 2023 (GLOBE NEWSWIRE) -- “According to the latest research study, the demand of “Induced Pluripotent Stem Cells Market accounted for US$ 1.8 billion in 2022 and is estimated to be...
11 oct. 2022 08h54 HE | Source: PMI

Organoids and Spheroids Market is estimated to be US$ 1234.51 Million by 2032 with a CAGR of 8.4% during the forecast period 2032 - By PMI

Covina, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Organoids and Spheroids are 3D cell cultures which are cultured by different techniques. Organoids helps in studying cell interaction in organ, drug...
14 avr. 2021 08h00 HE | Source: aTyr Pharma, Inc.

aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810

SAN DIEGO, April 14, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
09 juin 2020 10h35 HE | Source: PMI

Global Bio safety Testing Market is Estimated to be US$ 10.5 Billion by 2029 with a CAGR of 13.1% during the forecast Period - PMI

Covina, CA, June 09, 2020 (GLOBE NEWSWIRE) -- The global bio safety testing market accounted for US$ 3.1 billion in 2019 and is estimated to be US$ 10.5 billion by 2029 and is anticipated to...
22 oct. 2015 02h00 HE | Source: Mesoblast

Mesoblast Chairman's Address to 2015 Annual General Meeting

NEW YORK, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Thank you for attending the Mesoblast 2015 Annual General Meeting. This has been another exciting and productive year in the history of our...
25 août 2014 20h27 HE | Source: Mesoblast

Mesoblast Unveils Path to Bring Its Key Products to Market

NEW YORK and MELBOURNE, Australia, Aug. 25, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today reported 2014 financial results and unveiled its...
12 févr. 2013 20h28 HE | Source: Mesoblast

FDA Agreement on Mesoblast's Use of Singapore Manufacturing Facility for Clinical Trial Production of Proprietary Mesenchymal Precursor Cells

MELBOURNE, Australia, Feb. 12, 2013 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (OTC ADR:MBLTY) today announced that United States Food and Drug Administration (FDA) is in agreement for Mesoblast...